MIR520h: A Non-Coding RNA Molecule Implicated in Various Diseases

Target Name: MIR520H

NCBI ID: G574493

MIR520H

Other Name(s): microRNA 520h | MicroRNA 520h | hsa-mir-520h | hsa-miR-520h | MIRN520H

MIR520h: A Non-Coding RNA Molecule Implicated in Various Diseases

MicroRNA (miRNA) 520h is a non-coding RNA molecule that plays a crucial role in various cellular processes. It is a key regulator of gene expression and has been implicated in a wide range of biological processes, including cell growth, differentiation, and apoptosis . MIR520h is a potential drug target and has been identified as a potential biomarker for various diseases, including cancer.

MIR520h is a member of the miRNA family, which consists of approximately 200 non-coding RNAs that play a central role in post-transcriptional gene regulation. miRNAs are designed to target specific mRNAs for degradation, and their effects on gene expression can be inhibited by complementary small interfering RNA (siRNA). MIR520h is a single-stranded RNA molecule that contains 19 amino acid residues and has a calculated molecular weight of 23.8 kDa.

MIR520h is expressed in a variety of tissues and cells, including the brain, heart, and various cancers. It has been shown to play a role in cell proliferation, differentiation, and apoptosis. For example, MIR520h has been shown to be involved in the regulation of cell cycle progression and has been implicated in the development of cancer. Additionally, MIR520h has been shown to play a role in the regulation of cellular processes that are critical for maintaining tissue homeostasis, such as cell adhesion and migration.

MIR520h has also been shown to be involved in the regulation of inflammation. It has been shown to play a role in the regulation of the immune response and has been implicated in the development of various inflammatory diseases, including cancer. Additionally, MIR520h has been shown to play a role in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and apoptosis, and is a key factor in the development of cancer.

In addition to its role in cellular processes, MIR520h has also been shown to be involved in the regulation of gene expression. It has been shown to interact with various protein molecules, including transcription factors, to regulate the translation of RNA into protein. Additionally, MIR520h has been shown to play a role in the regulation of microRNA (miRNA) expression, which is a crucial mechanism of post-transcriptional gene regulation.

MIR520h has also been shown to be involved in the development of various diseases, including cancer. For example, it has been shown to play a role in the development of breast cancer by regulating the expression of genes involved in cell growth and differentiation. Additionally, MIR520h has been shown to play a role in the development of neurodegenerative diseases, including Alzheimer's disease, by regulating the expression of genes involved in cell death and inflammation.

In conclusion, MIR520h is a non-coding RNA molecule that plays a crucial role in various cellular processes. It is a potential drug target and has been identified as a potential biomarker for a wide range of diseases, including cancer. Further research is needed to fully understand the role of MIR520h in cellular processes and its potential as a drug target and biomarker.

Protein Name: MicroRNA 520h

The "MIR520H Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR520H comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets